Solazyme | Committee Composition

	Audit	Nominating and Corporate Governance	Compensation
Michael V. Arbige, Ph.D.
Michael V. Arbige has been a member of our board of directors since 2005. From 1990 to the present, Dr. Arbige has held a variety of positions at Genencor, a division of Danisco US Inc., a diversified biotechnology company, and is currently its Executive Vice President of Research and Development, Dr. Arbige has held this position since 1999. He is responsible for all activities associated with managing and driving the research and development activities for the company. Dr. Arbige obtained his Ph.D. in Microbial Physiology and Genetics in 1982 from the University of New Hampshire. Dr. Arbige is a valuable member of the board of directors due to his experience in and knowledge of the biotechnology sector.
Ian T. Clark
Ian T. Clark has been a member of our board of directors since April 2011. Mr. Clark is currently the chief executive officer and head of North American commercial operations at Genentech, a wholly-owned member of the Roche Group. From 2009 to 2010, he was a member of the board of directors of Dendreon Corporation and served on its Corporate Governance Committee. Prior to January 2010, he was head of global product strategy and chief marketing officer at Roche, Pharma Division since March 2009. Mr. Clark previously was executive vice president of commercial operations since 2006, senior vice president of commercial operations since 2005, and senior vice president of oncology commercial operations for Genentech's BioOncology business unit since 2003, which focused on global commercialization of the company's diverse oncology pipeline, including Avastin ® , Rituxan ® and Herceptin ® . Prior to his time at Genentech, Mr. Clark was president of Novartis Canada from 2001 to 2003 and chief operating officer of Novartis United Kingdom from 1999 to 2001, and also served on the Board of Directors of Vernalis, a pharmaceutical company, from 2007 to 2009. Mr. Clark received a B.S. in biological sciences from Southampton University in the United Kingdom. Mr. Clark is a valuable member of the board of directors due to his experience in and knowledge of the biotechnology sector and his leadership experience.
Jerry Fiddler
Jerry Fiddler has been a member and the chairman of our board of directors since 2004. From 1981 to 2009 Mr. Fiddler was, at various times, the founder, Chief Executive Officer, Chairman and/or director of Wind River Systems, Inc., a publicly held software company, until it was acquired by Intel Corporation, a semiconductor company. Mr. Fiddler is the principal/CEO of Zygote Ventures, LLC, and an adjunct professor at University of California, Berkeley. He serves on a number of private company and non-profit boards. Mr. Fiddler obtained an M.S. from the University of Illinois. Mr. Fiddler is a valuable member of the board of directors due to his 97 and corporate governance experience, his experience as CEO and chairman of a public company, his service on the boards of directors of other private companies and non-profit entities and his extensive knowledge of the company due to his service on the board of directors since 2004, which brings historic understanding and continuity to the board of directors.
William D. Lese
William D. Lese has been a member of our board of directors since 2008. Mr. Lese co-founded and since 2002 has served as a managing partner of Braemar Energy Ventures, LP, a venture capital management company, focused exclusively on investing in early to mid-stage energy technology companies predominantly located in the United States and Canada. Mr. Lese holds a B.A. in Physics and a M.Sc. in Energy Sciences from New York University. Mr. Lese is a valuable member of the board of directors due to his experience in and knowledge of the technology sector and his knowledge of energy and environmental businesses.
Ann Mather
Ann Mather has been a member of our board of directors since April 2011. Ms. Mather has also been a member of the board of directors of: Google Inc., an online search provider, since November 2005, and serves as chair of its Audit Committee; MGM Holdings Inc., a motion picture and television production and distribution company, since December 2010, and serves on its Compensation Committee; MoneyGram International, a global payment services company, since May 2010; and Netflix, Inc., an internet subscription service for movies and television shows, since July 2010, and serves on its Audit Committee. She also serves as a board member to Glu Mobile Inc., a publisher of mobile games, since September 2005, and formerly served as chair of its Audit Committee. Ann has also been an independent trustee to the Dodge & Cox Funds board of trustees since May 2011. Ann was previously a director of Central European Media Enterprises Group, a developer and operator of national commercial television channels and stations in Central and Eastern Europe, from 2004 to 2009. From 1999 to 2004, Ann was Executive Vice President and Chief Financial Officer of Pixar, a computer animation studio. Prior to her service at Pixar, Ann was Executive Vice President and Chief Financial Officer at Village Roadshow Pictures, the film production division of Village Roadshow Limited. Ann holds a Master of Arts degree from Cambridge University in England and is a chartered accountant.

= Chair of the Board

= Chair

= Member